Allergan (NYSE:AGN) announces a quarterly dividend of $0.72

ME Staff

7 years ago

Allergan (NYSE:AGN) to go ex-dividend.On 2/9/2018 Allergan ( NYSE:AGN ) announced that it will be issuing a quarterly dividend in the amount of $0.72 down from Previous Dividend: $0.70  $0.72 making the yield 0.00438489646772229%.Allergan (NYSE:AGN) Ex- dividend dateAllergan (NYSE:AGN) is set to go ex-dividend on and will be payable on 3/28/2018 Dividend History for Allergan (NYSE:AGN) The next payable dividend for Allergan is scheduled for 3/28/2018. There is an annual dividend of $$2.80 with a yield of 1.73% The company’s dividend has increased by 141.00% on a 3 Year Average The payout ration for the trailing 12 months of earnings is -23.35% , 18.13% based on this years estimates and 17.03% based on next years projected estimates.Recent Dividend History for Allergan (NYSE:AGN)

On 2/6/2013 Allergan announced a quarterly dividend of $0.05.
On 5/2/2013 Allergan announced a quarterly dividend of $0.05.
On 7/31/2013 Allergan announced a quarterly dividend of $0.05.
On 10/30/2013 Allergan announced a quarterly dividend of $0.05.
On 2/5/2014 Allergan announced a quarterly dividend of $0.05.
On 5/7/2014 Allergan announced a quarterly dividend of $0.05.

Recent Insider Trading for Allergan (NYSE:AGN)

On 12/7/2017 Chris W. Bodine, Director, bought 3,030 with an average share price of $164.77 per share and the total transaction amounting to $499,253.10.
On 12/6/2017 Brent L. Saunders, Chairman, bought 4,600 with an average share price of $164.74 per share and the total transaction amounting to $757,804.00.
On 12/5/2017 Christopher J. Coughlin, Director, bought 10,000 with an average share price of $163.30 per share and the total transaction amounting to $1,633,000.00.
On 12/1/2017 William Meury, Insider, sold 11,807 with an average share price of $173.89 per share and the total transaction amounting to $2,053,119.23.
On 5/18/2017 Nesli Basgoz, Director, sold 1,889 with an average share price of $220.45 per share and the total transaction amounting to $416,430.05.
On 3/2/2017 Paul Bisaro, Director, sold 70,000 with an average share price of $246.68 per share and the total transaction amounting to $17,267,600.00.

Recent Analyst Rating for Allergan (NYSE:AGN)

On 2/7/2018 Credit Suisse Group, Boost Price Target, fromOutperform to Outperform to Outperform with a price target of $214.00 to $215.00
On 2/7/2018 Bank of America, Boost Price Target, fromBuy to Buy to Buy with a price target of $208.00 to $215.00
On 2/7/2018 Leerink Swann, Boost Price Target, fromOutperform to Outperform to Outperform with a price target of $237.00 to $242.00
On 2/6/2018 Cantor Fitzgerald, Reiterated Rating, to Hold with a price target of $191.00
On 1/29/2018 Barclays, Upgrade, fromEqual Weight to Overweight to Equal Weight with a price target of $220.00 to $230.00
On 1/24/2018 Morgan Stanley, Reiterated Rating, to bought

Recent Trading for Allergan (NYSE:AGN) Shares of Allergan closed the previous trading session at 161.57 down -2.63 1.60% with 160.61500549316406 shares trading hands.